Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

5.81
Delayed Data
As of Jul 31
 +0.06 / +1.04%
Today’s Change
2.98
Today|||52-Week Range
8.59
+22.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues6.0M6.1M26.9M6.6M
 
 
 
 
 
Cost of Goods Sold10.5M11.3M12.2M11.2M
 
 
 
 
 
Depreciation And Amortization930.0K876.0K929.0K971.0K
 
 
 
 
 
 
Operating ExpensesGross Income-5.4M-6.1M13.8M-5.5M
 
 
 
 
 
General Expenses20.4M19.0M19.9M20.0M
 
 
 
 
 
Research And Development14.5M12.2M11.8M11.8M
 
 
 
 
 
Total Operating Expenses31.8M31.2M33.0M32.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.8M-25.1M-6.1M-25.5M
 
 
 
 
 
Interest Expense On Debt2.5M2.5M2.5M2.6M
 
 
 
 
 
Other Expenses0.000.000.0086.4M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.2M-27.6M-8.6M58.3M
 
 
 
 
 
Net Income-28.2M-27.6M-8.6M58.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS126.8M131.8M133.8M139.8M
 
 
 
 
 
Shares To Calculate EPS Diluted126.8M131.8M133.8M166.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.21-$0.06$0.37
 
 
 
 
 
EPS Diluted-$0.22-$0.21-$0.06$0.37